长期新冠肺炎的补充和替代药物:随机对照试验的系统综述。

IF 3.3 3区 医学 Q2 PHARMACOLOGY & PHARMACY
Therapeutic Advances in Chronic Disease Pub Date : 2023-10-11 eCollection Date: 2023-01-01 DOI:10.1177/20406223231204727
Juan Yang, Kia Hui Lim, Kia Teng Lim, Jeffrey T Woods, Arya B Mohabbat, Dietlind L Wahner-Roedler, Ravindra Ganesh, Brent A Bauer
{"title":"长期新冠肺炎的补充和替代药物:随机对照试验的系统综述。","authors":"Juan Yang, Kia Hui Lim, Kia Teng Lim, Jeffrey T Woods, Arya B Mohabbat, Dietlind L Wahner-Roedler, Ravindra Ganesh, Brent A Bauer","doi":"10.1177/20406223231204727","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Complementary and alternative medicine (CAM) interventions are growing in popularity as possible treatments for long COVID symptoms. However, comprehensive analysis of current evidence in this setting is still lacking.</p><p><strong>Objective: </strong>This study aims to review existing published studies on the use of CAM interventions for patients experiencing long COVID through a systematic review.</p><p><strong>Design: </strong>Systematic review of randomized controlled trials (RCTs).</p><p><strong>Methods: </strong>A comprehensive electronic literature search was performed in multiple databases and clinical trial registries from September 2019 to January 2023. RCTs evaluating efficacy and safety of CAM for long COVID were included. Methodological quality of each included trial was appraised with the Cochrane 'risk of bias' tool. A qualitative analysis was conducted due to heterogeneity of included studies.</p><p><strong>Results: </strong>A total of 14 RCTs with 1195 participants were included in this review. Study findings demonstrated that CAM interventions could benefit patients with long COVID, especially those suffering from neuropsychiatric disorders, olfactory dysfunction, cognitive impairment, fatigue, breathlessness, and mild-to-moderate lung fibrosis. The main interventions reported were self-administered transcutaneous auricular vagus nerve stimulation, neuro-meditation, dietary supplements, olfactory training, aromatherapy, inspiratory muscle training, concurrent training, and an online breathing and well-being program.</p><p><strong>Conclusion: </strong>CAM interventions may be effective, safe, and acceptable to patients with symptoms of long COVID. However, the findings from this systematic review should be interpreted with caution due to various methodological limitations. More rigorous trials focused on CAM for long COVID are warranted in the future.</p>","PeriodicalId":22960,"journal":{"name":"Therapeutic Advances in Chronic Disease","volume":null,"pages":null},"PeriodicalIF":3.3000,"publicationDate":"2023-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b2/97/10.1177_20406223231204727.PMC10571674.pdf","citationCount":"0","resultStr":"{\"title\":\"Complementary and alternative medicine for long COVID: a systematic review of randomized controlled trials.\",\"authors\":\"Juan Yang, Kia Hui Lim, Kia Teng Lim, Jeffrey T Woods, Arya B Mohabbat, Dietlind L Wahner-Roedler, Ravindra Ganesh, Brent A Bauer\",\"doi\":\"10.1177/20406223231204727\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Complementary and alternative medicine (CAM) interventions are growing in popularity as possible treatments for long COVID symptoms. However, comprehensive analysis of current evidence in this setting is still lacking.</p><p><strong>Objective: </strong>This study aims to review existing published studies on the use of CAM interventions for patients experiencing long COVID through a systematic review.</p><p><strong>Design: </strong>Systematic review of randomized controlled trials (RCTs).</p><p><strong>Methods: </strong>A comprehensive electronic literature search was performed in multiple databases and clinical trial registries from September 2019 to January 2023. RCTs evaluating efficacy and safety of CAM for long COVID were included. Methodological quality of each included trial was appraised with the Cochrane 'risk of bias' tool. A qualitative analysis was conducted due to heterogeneity of included studies.</p><p><strong>Results: </strong>A total of 14 RCTs with 1195 participants were included in this review. Study findings demonstrated that CAM interventions could benefit patients with long COVID, especially those suffering from neuropsychiatric disorders, olfactory dysfunction, cognitive impairment, fatigue, breathlessness, and mild-to-moderate lung fibrosis. The main interventions reported were self-administered transcutaneous auricular vagus nerve stimulation, neuro-meditation, dietary supplements, olfactory training, aromatherapy, inspiratory muscle training, concurrent training, and an online breathing and well-being program.</p><p><strong>Conclusion: </strong>CAM interventions may be effective, safe, and acceptable to patients with symptoms of long COVID. However, the findings from this systematic review should be interpreted with caution due to various methodological limitations. More rigorous trials focused on CAM for long COVID are warranted in the future.</p>\",\"PeriodicalId\":22960,\"journal\":{\"name\":\"Therapeutic Advances in Chronic Disease\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.3000,\"publicationDate\":\"2023-10-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b2/97/10.1177_20406223231204727.PMC10571674.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Therapeutic Advances in Chronic Disease\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/20406223231204727\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic Advances in Chronic Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/20406223231204727","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

背景:补充和替代医学(CAM)干预措施作为长期新冠肺炎症状的可能治疗方法越来越受欢迎。然而,在这方面仍然缺乏对现有证据的全面分析。目的:本研究旨在通过系统综述,回顾现有已发表的关于长期新冠肺炎患者使用CAM干预措施的研究。设计:随机对照试验(RCT)的系统综述。方法:从2019年9月到2023年1月,在多个数据库和临床试验登记处进行全面的电子文献检索。纳入了评估CAM治疗长期新冠肺炎疗效和安全性的随机对照试验。每个纳入试验的方法学质量用Cochrane“偏倚风险”工具进行评估。由于纳入研究的异质性,进行了定性分析。结果:共有14项随机对照试验,1195名参与者被纳入本综述。研究结果表明,CAM干预措施可以使长期新冠肺炎患者受益,尤其是那些患有神经精神障碍、嗅觉功能障碍、认知障碍、疲劳、呼吸困难和轻度至中度肺纤维化的患者。报告的主要干预措施包括自我管理的经皮耳迷走神经刺激、神经冥想、膳食补充剂、嗅觉训练、芳香疗法、吸气肌训练、同时训练以及在线呼吸和健康计划。结论:CAM干预措施对有长期新冠肺炎症状的患者可能是有效、安全和可接受的。然而,由于各种方法的局限性,应谨慎解释这一系统审查的结果。未来有必要对长期新冠肺炎的CAM进行更严格的试验。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Complementary and alternative medicine for long COVID: a systematic review of randomized controlled trials.

Complementary and alternative medicine for long COVID: a systematic review of randomized controlled trials.

Complementary and alternative medicine for long COVID: a systematic review of randomized controlled trials.

Complementary and alternative medicine for long COVID: a systematic review of randomized controlled trials.

Background: Complementary and alternative medicine (CAM) interventions are growing in popularity as possible treatments for long COVID symptoms. However, comprehensive analysis of current evidence in this setting is still lacking.

Objective: This study aims to review existing published studies on the use of CAM interventions for patients experiencing long COVID through a systematic review.

Design: Systematic review of randomized controlled trials (RCTs).

Methods: A comprehensive electronic literature search was performed in multiple databases and clinical trial registries from September 2019 to January 2023. RCTs evaluating efficacy and safety of CAM for long COVID were included. Methodological quality of each included trial was appraised with the Cochrane 'risk of bias' tool. A qualitative analysis was conducted due to heterogeneity of included studies.

Results: A total of 14 RCTs with 1195 participants were included in this review. Study findings demonstrated that CAM interventions could benefit patients with long COVID, especially those suffering from neuropsychiatric disorders, olfactory dysfunction, cognitive impairment, fatigue, breathlessness, and mild-to-moderate lung fibrosis. The main interventions reported were self-administered transcutaneous auricular vagus nerve stimulation, neuro-meditation, dietary supplements, olfactory training, aromatherapy, inspiratory muscle training, concurrent training, and an online breathing and well-being program.

Conclusion: CAM interventions may be effective, safe, and acceptable to patients with symptoms of long COVID. However, the findings from this systematic review should be interpreted with caution due to various methodological limitations. More rigorous trials focused on CAM for long COVID are warranted in the future.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Therapeutic Advances in Chronic Disease
Therapeutic Advances in Chronic Disease Medicine-Medicine (miscellaneous)
CiteScore
6.20
自引率
0.00%
发文量
108
审稿时长
12 weeks
期刊介绍: Therapeutic Advances in Chronic Disease publishes the highest quality peer-reviewed research, reviews and scholarly comment in the drug treatment of all chronic diseases. The journal has a strong clinical and pharmacological focus and is aimed at clinicians and researchers involved in the medical treatment of chronic disease, providing a forum in print and online for publishing the highest quality articles in this area.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信